Page 805 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

12 References

361. Wood KA, Lewis L, Von Harz B, Kollef MH. The use of non- nosocomial respiratory tract infections among intensive care
invasive positive pressure ventilation in the emergency depart- unit patients. Infect Control Hosp Epidemiol. 2009;30:952-958.
ment: results of a randomized clinical trial. Chest. 1998;113: 378. DeRiso AJ 2nd, Ladowski JS, Dillon TA, Justice JW, Peterson
1339-1346. AC. Chlorhexidine gluconate 0.12% oral rinse reduces the
362. Antonelli M, Conti G. Noninvasive positive pressure ventilation incidence of total nosocomial respiratory infection and nonpro-
as treatment for acute respiratory failure in critically ill patients. phylactic systemic antibiotic use in patients undergoing heart
Crit Care. 2000;4:15-22. surgery. Chest. 1996;109:1556-1561.
363. Antonelli M, Conti G, Rocco M, et al. A comparison of nonin- 379. Genuit T, Bochicchio G, Napolitano LM, McCarter RJ, Roghman
vasive positive-pressure ventilation and conventional mechani- MC. Prophylactic chlorhexidine oral rinse decreases ventilator-
cal ventilation in patients with acute respiratory failure. N Engl associated pneumonia in surgical ICU patients. Surg Infect
J Med. 1998;339:429-435. (Larchmt). 2001;2:5-18.
364. Alexiou VG, Ierodiakonou V, Dimopoulos G, Falagas ME. 380. Koeman M, van der Ven AJ, Hak E, et al. Oral decontamination
Impact of patient position on the incidence of ventilator- with chlorhexidine reduces the incidence of ventilator-associated
associated pneumonia: a meta-analysis of randomized controlled pneumonia. Am J Respir Crit Care Med. 2006;173:1348-1355.
trials. J Crit Care. 2009. 381. Kollef MH. Prevention of hospital-associated pneumonia and
365. Scales DC, Dainty K, Hales B, et al. A multifaceted intervention ventilator-associated pneumonia. Crit Care Med. 2004;32:1396-
for quality improvement in a network of intensive care units: a 1405.
cluster randomized trial. JAMA. 2011;305:363-372. 382. Panchabhai TS, Dangayach NS, Krishnan A, Kothari VM,
366. Bouadma L, Deslandes E, Lolom I, et al. Long-term impact Karnad DR. Oropharyngeal cleansing with 0.2% chlorhexi-
of a multifaceted prevention program on ventilator-associated dine for prevention of nosocomial pneumonia in critically ill
pneumonia in a medical intensive care unit. Clin Infect Dis. patients: an open-label randomized trial with 0.01% potassium
2010;51:1115-1122. permanganate as control. Chest. 2009;135:1150-1156.
367. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. 383. Scannapieco FA, Yu J, Raghavendran K, et al. A randomized
Guidelines for preventing health-care—associated pneumonia, trial of chlorhexidine gluconate on oral bacterial pathogens in
2003: recommendations of CDC and the healthcare infection mechanically ventilated patients. Crit Care. 2009;13:R117.
control practices advisory committee. MMWR Recomm Rep. 384. Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de
2004;53:1-36. Mol BA. Prevention of nosocomial infection in cardiac surgery
368. Koenig SM, Truwit JD. Ventilator-associated pneumonia: by decontamination of the nasopharynx and oropharynx with
diagnosis, treatment, and prevention. Clin Microbiol Rev. chlorhexidine gluconate: a randomized controlled trial. JAMA.
2006;19:637-657. 2006;296:2460-2466.
369. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious 385. Silvestri L, van Saene HK, Milanese M, Zei E, Blazic M.
Diseases Society of America/American Thoracic Society con- Prevention of ventilator-associated pneumonia by use of oral
sensus guidelines on the management of community-acquired chlorhexidine. Infect Control Hosp Epidemiol. 2009;30:101-102;
pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72. author reply 2-3.
370. Masterton RG, Galloway A, French G, et al. Guidelines for 386. Silvestri L, van Saene HK, Zandstra DF, Viviani M, Gregori D.
the management of hospital-acquired pneumonia in the UK: SDD, SOD, or oropharyngeal chlorhexidine to prevent pneumo-
Report of the Working Party on Hospital-Acquired Pneumonia nia and to reduce mortality in ventilated patients: which manoeu-
of the British Society for Antimicrobial Chemotherapy. vre is evidence-based? Intensive Care Med. 2010;36:1436-1437.
J Antimicrob Chemother. 2008. 387. Tantipong H, Morkchareonpong C, Jaiyindee S, Thamlikitkul V.
371. Klompas M. Prevention of ventilator-associated pneumonia. Randomized controlled trial and meta-analysis of oral decon-
Expert Rev Anti Infect Ther. 2010;8:791-800. tamination with 2% chlorhexidine solution for the prevention of
372. Vincent JL, de Souza Barros D, Cianferoni S. Diagnosis, man- ventilator-associated pneumonia. Infect Control Hosp Epidemiol.
agement and prevention of ventilator-associated pneumonia: 2008;29:131-136.
an update. Drugs. 2010;70:1927-1944. 388. Chlebicki MP, Safdar N. Topical chlorhexidine for prevention
373. Choi SC, Nelson LD. Kinetic therapy in critically ill patients: com- of ventilator-associated pneumonia: a meta-analysis. Crit Care
bined results based on meta-analysis. J Crit Care. 1992;7:57-62. Med. 2007;35:595-602.
374. Traver GA, Tyler ML, Hudson LD, Sherrill DL, Quan SF. 389. Mahul P, Auboyer C, Jospe R, et al. Prevention of nosocomial
Continuous oscillation: outcome in critically ill patients. J Crit pneumonia in intubated patients: respective role of mechani-
Care. 1995;10:97-103. cal subglottic secretions drainage and stress ulcer prophylaxis.
375. Kollef M, Pittet D, Sanchez Garcia M, et al. A randomized Intensive Care Med. 1992;18:20-25.
double-blind trial of iseganan in prevention of ventilator- associated 390. Valles J, Artigas A, Rello J, et al. Continuous aspiration of sub-
pneumonia. Am J Respir Crit Care Med. 2006;173:91-97. glottic secretions in preventing ventilator-associated pneumonia.
376. Fourrier F, Dubois D, Pronnier P, et al. Effect of gingival and Ann Intern Med. 1995;122:179-186.
dental plaque antiseptic decontamination on nosocomial infec- 391. Kollef MH, Skubas NJ, Sundt TM. A randomized clinical trial of
tions acquired in the intensive care unit: a double-blind placebo- continuous aspiration of subglottic secretions in cardiac surgery
controlled multicenter study. Crit Care Med. 2005;33:1728-1735. patients [see comments]. Chest. 1999;116:1339-1346.
377. Bellissimo-Rodrigues F, Bellissimo-Rodrigues WT, Viana JM, 392. Bo H, He L, Qu J. [Influence of the subglottic secretion drain-
et al. Effectiveness of oral rinse with chlorhexidine in preventing age on the morbidity of ventilator associated pneumonia in

Section04-O-ref.indd 12 1/21/2015 11:23:26 AM